查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853471

微創胸腔外科手術市場按手術類型、產品、最終用戶、技術和應用分類－2025-2032年全球預測

Minimally Invasive Thoracic Surgery Market by Procedure Type, Product, End User, Technology, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，微創胸腔外科手術市場規模將達到 51.8 億美元，複合年成長率為 8.30%。

主要市場統計數據
基準年 2024 27.3億美元
預計年份：2025年 29.6億美元
預測年份：2032年 51.8億美元
複合年成長率 (%) 8.30%

一個簡潔的框架展示了程序、產品和機構動態如何融合，從而重新定義胸腔外科的病患診療路徑和臨床重點。

胸腔外科微創手術已進入一個新階段，手術流程、技術和醫療機構的優先事項相互交織，共同重塑手術模式和病患預後。過去十年，外科醫生和醫院系統不斷擴大微創技術的應用範圍，以降低手術全期併發症發生率、縮短復原時間並提高病患滿意度。這項轉變不僅反映了不斷發展的臨床證據，也得益於可視化技術、器械和平台整合方面的進步，使得複雜的胸腔外科手術能夠以更小的網路基地台和更高的精準度完成。

事實上，手術類型已擴展至多種選擇，從機器人輔助胸腔鏡手術到單孔入路和傳統視訊輔助手術，每種手術方式都存在不同的臨床權衡和工作流程影響。同時，產品創新集中在能量設備、精密器械、縫合系統和先進的可視化解決方案，從而為手術團隊建立了一個豐富的生態系統，以最佳化手術流程和結果。最終使用者的動態受到門診手術中心對高效當日手術流程的需求的影響，而醫院則繼續在區域手術需求和三級醫療的複雜性之間尋求平衡。技術架構涵蓋多孔、單孔和機器人系統，以滿足機構在成本、可擴展性和臨床適用性等方面的優先事項。

隨著相關人員考慮投資和實施策略，他們越來越關注手術選擇、設備相容性和設施準備如何共同決定治療路徑。本執行摘要整合了這些相互影響的因素，並為尋求將創新與永續臨床價值相結合的臨床領導者、醫院管理者、設備製造商和政策制定者提供了啟示。

整合平台的發展、流程的演變以及分散式醫療模式如何重塑胸腔外科手術實踐和採購選擇

胸腔外科領域正經歷一場變革，這場變革是由技術、臨床和操作趨勢的整合所驅動的。首先，機器人平台的成熟透過提高操作的靈活性和3D視覺化能力，改變了複雜切除手術的格局，從而拓展了以往微創手術的適應症。單孔技術的改進和視訊輔助內視鏡技術的增強，進一步推動了這一發展，使外科醫生能夠根據自身的臨床目標和機構能力選擇合適的手術方案。

其次，器械層面的創新正在加速從單一功能工具向整合系統的轉變，這些系統將能量傳輸、精準解剖和縫合釘放置整合到一致的手術流程中。先進的雙極和超音波能量器械能夠有效止血和處理組織，從而減少附帶熱損傷並縮短手術時間。提供高清影像和3D內視鏡的視覺化系統改善了術中決策，並減少了對開放性手術的依賴。諸如抓鉗、分離器和專用剪刀等器械經過反覆最佳化，在不影響人體工學的前提下，支持減少手術切口和單孔入路的策略。

第三，醫療服務模式正變得日益分散化，門診手術中心和社區醫院進行難度較低的胸腔外科手術，而三級醫療中心則專注於難度較高的病例和複雜的重組手術。這種醫療服務的重新分配要求產品系列和培訓路徑能夠支援在不同環境下的可擴展應用。最後，監管機構的關注和支付方的審查促使製造商和醫療服務提供者證明手術本身的價值、安全性和可重複性。這些轉變並非漸進式的，而是系統性的；它們正在改變介入措施的設計、實施和報銷方式，迫使相關人員重新思考臨床通訊協定、資金分配和培訓投資。

為因應關稅變化對採購、製造夥伴關係和合約價值模式的影響，供應鏈調整和籌資策略正在改變。

將於2025年生效的關稅調整，是影響整個醫療保健生態系統供應鏈策略、採購時機和成本轉嫁的重要外部因素。為此，製造商和醫療機構的採購團隊正在重新審視其採購佈局和庫存策略，以減輕進口關稅上漲的影響，並確保關鍵物資的持續供應。這促使他們更加關注近岸外包、供應商網路多元化以及重新談判合約條款，並更加重視總體擁有成本而非僅僅關注單價。

除了供應商選擇之外，臨床醫生和手術室管理人員也開始評估產品的模組化和可重複使用性，作為在成本限制更加嚴格的情況下維持手術能力的手段。例如，支援更廣泛器械和耗材的系統，透過減少對多種單一用途器械的需求，提高了採購效率。同時，關稅主導的價格調整的可能性，也促使設備製造商和醫院集團之間就批量採購和基本契約展開更深入的合作對話。這些安排既能實現風險共擔，又能確保獲得維持臨床品質所需的先進醫療設備。

重要的是，關稅環境正在加速圍繞本地製造夥伴關係和技術轉移協議的策略決策。相關人員越來越重視在低關稅地區建立組裝和零件製造工廠，以保護淨利率並穩定供應。雖然這些營運模式的轉變不會改變臨床適應症或外科手術創新的發展軌跡，但它們將改變新工具在不同地區推廣的速度，以及哪些供應商會成為醫院系統和門診手術中心的長期策略夥伴。

深入分析細分相關流程選擇、設備模式細微差別、設施要求和特定應用臨床需求，以闡明其應用。

細分市場分析提供了一個視角，幫助我們了解不同手術類型、產品類型、最終用戶、技術和應用領域的採用模式、臨床適用性和購買行為。在選擇手術類型時，臨床醫生會權衡機器人輔助胸腔鏡手術、單孔胸腔鏡手術和影片輔助胸腔鏡手術之間的利弊，並平衡精度、學習曲線和手術室佔用空間等因素，以確定哪種手術最適合其所在機構的病例組合。能量設備（例如先進的雙極電凝系統、電凝器和超音波系統）的選擇是基於其止血性能和溫度曲線，而器械（例如分離器、抓鉗和剪刀）則需評估其人體工學設計以及與手術入路和手術方式的兼容性。縫合器和拋棄式仍然是組織切割和吻合的必需品，而從高解析度平台到3D內視鏡和2D內視鏡等視覺化系統，對術中決策和訓練路徑有著顯著的影響。

終端使用者細分突顯了門診手術中心和醫院的不同需求。門診手術中心優先考慮精簡的工作流程、快速的周轉和經濟高效的拋棄式，而醫院（包括社區醫院和三級醫療中心）則需要可擴展性，以支持複雜的手術切除、多學科團隊以及術後強化護理。技術細分錶明，多孔、機器人和單孔系統在資金投入、維護和培訓方面各有不同，這會影響採購時間表和部署策略。最後，將應用場景分為診斷和治療兩類，揭示了儀器和視覺化選擇如何取決於主要目標是精確定位病灶還是進行治療性切除和重組。

綜合來看，市場區隔表明，競爭定位取決於滿足跨領域的要求，例如臨床療效、設備在不同手術方法中的兼容性、減少採用障礙的服務和培訓產品，以及能夠引起門診中心和大型醫院共鳴的價值提案。

在全球市場中，醫療保健系統和採購現實的區域差異如何影響技術採納、培訓重點和商業化策略

美洲、歐洲、中東和非洲以及亞太地區的區域動態正在影響技術的擴散、報銷管道和普及率，而每個區域都有其獨特的結構性促進因素。在美洲營運的相關人員常常面臨複雜的環境：先進的三級醫療中心引領機器人和單孔器材的普及，而社區醫院和門診中心則在評估經濟高效的器材平台，以擴大微創手術的覆蓋範圍。該地區的報銷模式影響著採購週期以及對有望提高營運效率的資本密集系統的投資意願。

在歐洲、中東和非洲，醫療體系組織和採購實務的差異導致了醫療技術應用路徑的多樣性。有些市場強調集中採購和國家層級的臨床效用評估，在證據充分的情況下加速推廣應用；而有些市場則因成本效益檢驗不足而延後應用。同時，中東部分私人醫療機構正迅速採用高階平台，以滿足病患對先進醫療服務的需求。在亞太地區，大型手術中心和快速發展的區域性醫院共同推動了複雜影片輔助手術的普及，並在手術量足以支撐資本支出的情況下，對機器人手術平台的興趣日益濃厚。該地區的供應鏈韌性和在地化生產措施也在塑造商業策略和服務模式方面發揮關鍵作用。

整體而言，區域策略必須根據當地的報銷結構、訓練體系成熟度和醫療機構能力量身訂做。能夠提供符合當地實際情況的產品組合、服務覆蓋範圍和培訓項目的供應商和醫療系統，將能夠有效地滲透多元化市場，並支持永續的推廣管道。

競爭格局分析：揭示平台現有企業、專業創新和夥伴關係主導的策略，這些策略共同定義了差異化的市場定位。

該領域的競爭格局由成熟的平台供應商、專業設備製造商以及專注於能量、縫合和可視化技術的創新新興企業組成。專業公司透過專注於差異化的性能屬性，例如精密的能量曲線、超薄縫合技術和超高清3D成像，在特定手術領域不斷擴大市場佔有率。

隨著企業尋求平台存取和一流耗材，合作模式日益普遍。夥伴關係和培訓生態系統是關鍵的競爭優勢，縮短學習曲線並提供穩定結果的能力會影響醫院和門診中心的採購決策。此外，提供涵蓋模擬培訓、測試監督和性能分析等全面支持項目的製造商，將自身定位為臨床品質改進的合作夥伴，而不僅僅是供應商。

新參與企業正透過滿足尚未充分滿足的需求來開闢市場，例如面向門診環境的低成本設備以及針對單埠工作流程最佳化的緊湊型視覺化系統。同時，現有企業則利用裝置量、長期服務合約以及數據主導的療效證據來鞏固自身地位。這些動態意味著，競爭優勢將越來越取決於企業能否打造整合設備效能、臨床培訓和商業性彈性的端到端價值提案。

為設備開發商和醫療保健系統提供可操作的策略重點，以將技術能力轉化為持續的臨床應用和商業性韌性。

產業領導者應優先考慮將技術開發、商業模式和臨床應用管道結合的策略，以加速永續推廣。首先，投資於互通性和模組化架構，使設備和耗材能夠在多個平台和手術方法中使用，將降低醫院的轉換成本，並促進在區域和三級醫療機構的廣泛部署。其次，開發結合模擬、指導和開發後分析的完善的培訓和認證項目，將縮短外科醫生採用機器人手術、單孔手術或高級視訊輔助手術的學習曲線。

第三，我們將與醫院和門診中心採取靈活的合約模式，納入配套服務、結果掛鉤條款和風險分擔機制。此類商業性創新將有助於緩解預算壓力，並建立永續的採購關係。第四，我們將透過調整產品組合和支援服務，使其與當地的報銷制度和供應鏈相適應，從而加強本地市場推廣策略。最後，我們將致力於收集和發布真實世界的臨床結果，以證明無論手術類型或技術如何，其療效和安全性均具有可比性，從而支持臨床應用和與支付方的對話。

透過實施這些策略重點，產業領導者可以將技術能力轉化為持久的臨床影響，同時解決影響醫院和門診病人採購決策的營運和預算限制。

採用綜合混合方法，結合關鍵相關人員參與、臨床證據審查、設備評估和供應鏈分析，以獲取可操作的情報。

本初步研究採用混合方法，結合了主要相關人員訪談、臨床文獻回顧、器械技術評估和供應鏈分析，以全面了解微創胸腔外科手術。主要訪談對象包括外科負責人、醫院採購主管、門診手術中心管理人員和器械公司產品經理，旨在了解實際決策標準、推廣障礙和服務期望。臨床文獻回顧著重於比較研究、手術流程描述和安全性分析，以了解手術選擇如何影響手術結果和工作流程。

設備評估檢視了設計特點、互通性、服務模式和培訓方案，以評估產品規格如何影響其在不同環境下的應用。供應鏈和採購分析檢視了籌資策略、關稅覆蓋範圍和區域製造因素，以確定相關人員用於管理成本和業務連續性風險的營運手段。在條件允許的情況下，研究結果透過多重資料來源進行三角驗證，以檢驗模式並最大限度地減少單一資料來源的偏差。

在整個調查方法中，我們較少關注產生說明清單，而更注重提取可操作的情報以支援策略決策。此方法的局限性包括報告慣例的區域差異以及各機構對程序結果看法的不同，但我們透過優先考慮三角驗證和專家檢驗來解決這些問題。

面向未來的整合方案，強調設備設計、臨床培訓和商業性適應性的整合，以確保廣泛且持續的應用。

總之，微創胸腔外科手術正處於曲折點，器械創新、手術流程改善和醫療服務模式的轉變共同塑造未來的發展方向。手術方式的選擇、產品性能和醫療機構的準備之間的相互作用，不僅決定臨床結果，也決定技術應用的速度和規模。隨著供應鏈壓力和關稅變化對商業動態的影響，相關人員必須採取統籌兼顧採購、培訓和臨床管治的整體策略。

展望未來，最成功的機構將是那些整合模組化產品設計、強大的服務和培訓體係以及在地化商業模式的機構。透過優先考慮互通性、真實世界證據的生成以及靈活的合約條款，製造商和醫療服務提供者可以在控制財務和營運風險的同時，支持微創胸腔外科手術的廣泛普及。最終目標是確保臨床進展能夠轉化為患者照護的可衡量改進，並惠及從門診中心到三級醫院等各種醫療機構。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 提高單孔胸腔鏡輔助手術技術的應用率，以縮短患者復健時間
  • 結合影像導引與人工智慧技術，實現高精度微創肺腫瘤切除
  • 擴增實境導航系統的出現可改善胸腔外科手術中外科醫師的視野
  • 研發能夠以最小創傷到達難以觸及的肺結節的軟性內視鏡器械。
  • 在微創胸腔外科手術中增加門診和當日出院通訊協定
  • 能量型密封裝置的進步可減少胸腔鏡手術中的術中出血
  • 增加遠端監控平台的投資，用於虛擬外科醫生培訓和微創手術技能評估

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 微創胸腔外科手術市場（依手術類型分類）

  • 機器人輔助胸腔鏡手術
  • Uniportal VATS
  • 視訊輔助胸腔鏡手術

第9章 微創胸腔外科市場：依產品分類

  • 能源設備
    • 先進的雙極元件
    • 電灼
    • 超音波
  • 裝置
    • 解剖器
    • 抓鉗
    • 剪刀
  • 訂書機和一次性用品
  • 視覺化系統
    • 高解析度系統
    • 3D內視鏡
    • QR 圖內視鏡

第10章 依最終用戶分類的微創胸腔外科手術市場

  • 門診手術中心
  • 醫院
    • 社區醫院
    • 三級醫療中心

第11章 微創胸腔外科市場：依技術分類

  • 多埠系統
  • 機器人系統
  • 單埠系統

第12章 微創胸腔外科市場：依應用領域分類

  • 診斷
  • 治療

第13章 微創胸腔外科市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 微創胸腔外科市場（依集團分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國微創胸腔外科手術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Intuitive Surgical, Inc.
    • Johnson & Johnson
    • Medtronic plc
    • Smith & Nephew plc
    • Stryker Corporation
    • Olympus Corporation
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • KARL STORZ SE & Co. KG
    • CONMED Corporation
Product Code: MRR-3A2E844FEF43

The Minimally Invasive Thoracic Surgery Market is projected to grow by USD 5.18 billion at a CAGR of 8.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.73 billion
Estimated Year [2025] USD 2.96 billion
Forecast Year [2032] USD 5.18 billion
CAGR (%) 8.30%

Concise framing of how procedural, product, and institutional dynamics converge to redefine patient pathways and clinical priorities in thoracic surgery

Minimally invasive approaches to thoracic surgery have entered a phase where technique, technology, and institutional priorities intersect to reshape surgical pathways and patient outcomes. Over the past decade, surgeons and hospital systems have steadily expanded adoption of less invasive procedures to reduce perioperative morbidity, shorten recovery timelines, and improve patient satisfaction. This shift reflects not only evolving clinical evidence but also advances in visualization, instrumentation, and platform integration that enable complex thoracic procedures to be executed with smaller access points and enhanced precision.

In practice, procedure type choices have broadened to include an array of options-ranging from robotic assisted thoracoscopic surgery to uniportal approaches and conventional video-assisted techniques-each offering distinct clinical trade-offs and workflow implications. Concurrently, product innovation has centered on energy devices, refined instruments, staple systems and advanced visualization solutions, creating a richer ecosystem for surgical teams to optimize techniques and outcomes. End-user dynamics have been shaped by ambulatory surgical centers seeking efficient, same-day workflows while hospitals continue to balance community-level procedural demand with tertiary care complexity. Technology architectures, spanning multi-port to single-port and robotic systems, respond to institutional priorities for cost, scalability, and clinical versatility.

As stakeholders evaluate investment and adoption strategies, attention increasingly falls on how procedural selection, device compatibility, and facility readiness converge to define pathways of care. This executive summary synthesizes those converging forces and frames implications for clinical leaders, hospital administrators, device manufacturers, and policy-makers aiming to align innovation with sustainable clinical value.

How integrated platform advancements, procedural technique evolution, and care model decentralization are jointly reshaping thoracic surgery practice and procurement choices

The landscape for thoracic surgery is undergoing transformative shifts driven by converging technological, clinical, and operational trends. First, maturation of robotic platforms has altered the calculus for complex resections by improving dexterity and three-dimensional visualization, which in turn has expanded indications where minimally invasive approaches were previously constrained. This evolution is complemented by refinement in uniportal techniques and enhancements in video-assisted endoscopy, enabling surgeons to select an approach that matches clinical goals and institutional capacity.

Second, device-level innovation has accelerated the transition from single-function tools to integrated systems that combine energy delivery, precision dissection, and stapling within a cohesive procedural workflow. Advanced bipolar and ultrasonic energy modalities address hemostasis and tissue handling in ways that reduce collateral thermal injury and streamline operative time. Visualization systems that provide high-definition imaging and 3D endoscopes have improved intraoperative decision-making and reduced reliance on open conversions. Instruments such as graspers, dissectors, and specialized scissors have been iteratively optimized to support port reduction strategies and single-site access without compromising ergonomics.

Third, care delivery models are shifting toward greater decentralization, with ambulatory surgical centers and community hospitals increasingly performing lower-complexity thoracic procedures while tertiary centers focus on high-acuity cases and complex reconstructions. This redistribution of care necessitates product portfolios and training pathways that support scalable adoption across diverse settings. Finally, regulatory attention and payer scrutiny are prompting manufacturers and providers to demonstrate procedure-level value, safety, and reproducibility. Taken together, these shifts are not incremental but systemic: they change how interventions are designed, delivered, and reimbursed, compelling stakeholders to reassess clinical protocols, capital allocation, and training investments.

Supply chain adaptations and procurement strategies responding to tariff shifts that influence sourcing, manufacturing partnerships, and contractual value models

Tariff changes effective in 2025 represent an important external driver influencing supply chain strategy, procurement timing, and cost pass-through across the healthcare ecosystem. In response, manufacturers and institutional purchasing teams have been reassessing sourcing footprints and inventory policies to mitigate exposure to increased import duties and to maintain continuity of critical supplies. This has prompted heightened interest in nearshoring options, diversified supplier networks, and renegotiated contractual terms that emphasize total cost of ownership rather than unit price alone.

Beyond supplier selection, clinicians and operating room managers have begun to evaluate product modularity and reusability as levers to preserve procedural capacity under tighter cost constraints. For example, systems that support a broader range of instruments and consumables offer purchasing efficiencies by reducing the need for multiple single-purpose devices. At the same time, the potential for tariff-driven price adjustments has strengthened collaborative dialogues between device companies and hospital groups about bundled procurement and value-based contracting. These arrangements allow risks to be shared while ensuring access to advanced devices necessary for maintaining clinical quality.

Importantly, the tariff environment also accelerates strategic decisions around local manufacturing partnerships and technology transfer agreements. Stakeholders are increasingly weighing the benefits of establishing assembly or component production within lower-tariff jurisdictions to protect margins and stabilize supply. While these operational shifts do not alter clinical indications or the trajectory of surgical innovation, they do change how quickly new tools are adopted across regions and which suppliers become strategic long-term partners for hospital systems and ambulatory centers alike.

Deep-dive segmentation perspective linking procedural choices, device modality nuances, institutional requirements, and application-specific clinical demands for adoption clarity

Segment analysis provides a lens to understand differentiated adoption patterns, clinical suitability, and purchasing behavior across procedure types, products, end users, technologies, and applications. When examining procedure types, clinicians weigh the trade-offs among robotic assisted thoracoscopic surgery, uniportal VATS, and video-assisted thoracoscopic surgery, balancing factors such as precision, learning curve, and operating room footprint to determine the right fit for institutional case mix. Product portfolios require similar nuance: energy devices including advanced bipolar, electrocautery, and ultrasonic systems are selected based on hemostatic performance and thermal profile, while instruments such as dissectors, graspers, and scissors are assessed for ergonomics and compatibility with port size and approach. Staplers and disposables remain essential for tissue transection and anastomosis, and visualization systems from high-definition platforms to three-dimensional endoscopes and two-dimensional options materially affect intraoperative decision-making and training pathways.

End-user segmentation highlights divergent needs between ambulatory surgical centers and hospitals, where ambulatory settings prioritize streamlined workflows, rapid turnover, and cost-effective disposables, whereas hospitals - encompassing both community hospitals and tertiary care centers - require scalability to support complex resections, multidisciplinary teams, and intensive postoperative care. Technology segmentation illuminates how multi-port systems, robotic systems, and single-port systems each present different capital, maintenance, and training profiles that influence procurement timelines and deployment strategies. Lastly, the application split between diagnostic and therapeutic use cases underscores how instrumentation and visualization choices are driven by whether the primary objective is precise lesion localization or therapeutic resection and reconstruction.

Taken together, segmentation reveals that competitive positioning depends on addressing cross-cutting requirements: clinical efficacy, instrument compatibility across procedural approaches, service and training offerings that reduce the barrier to adoption, and value propositions that resonate with both ambulatory centers and high-volume tertiary hospitals.

How regional healthcare system variation and procurement realities govern technology adoption, training priorities, and commercialization strategies across global markets

Regional dynamics shape technology diffusion, reimbursement pathways, and adoption velocity across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct structural drivers. Stakeholders operating in the Americas often encounter a mixed environment where advanced tertiary centers lead in robotic and single-port adoption while community hospitals and ambulatory centers evaluate cost-effective instrument platforms to expand minimally invasive access. Reimbursement models in this region influence purchasing cycles and the willingness to invest in capital-intensive systems that promise operational efficiencies.

In Europe, Middle East & Africa, variation in health system organization and procurement practices creates a mosaic of adoption trajectories. Some markets emphasize centralized procurement and national-level assessments of clinical benefit, which can either accelerate uptake when evidence is favorable or slow adoption pending cost-effectiveness reviews. Meanwhile, private healthcare segments in parts of the Middle East display rapid uptake of premium platforms aligned with patient demand for advanced care. Across Asia-Pacific, a mix of high-volume surgical centers and rapidly maturing community hospitals drives parallel adoption of refined video-assisted techniques and an increasing interest in robotic platforms where surgical volumes justify the capital outlay. Supply chain resilience and local manufacturing initiatives in this region also play a significant role in shaping commercial strategies and service models.

Overall, regional strategies must be tailored to local reimbursement structures, training ecosystem maturity, and facility-level capabilities. Vendors and health systems that align product configurations, service footprints, and training programs with regional realities can more effectively penetrate diverse markets and support sustainable adoption pathways.

Competitive landscape insights revealing platform incumbency, specialist innovation, and partnership-led strategies that define differentiated market positioning

Competitive dynamics in this field reflect a mix of established platform providers, specialist instrument manufacturers, and emerging firms offering focused innovations in energy, stapling, and visualization. Leading platform providers continue to invest in modularity and interoperability to reduce lock-in and broaden clinical reach, while specialist companies focus on differentiated performance characteristics-such as refined energy profiles, low-profile stapling technologies, or ultra-high-definition three-dimensional imaging-to capture share within specific procedure segments.

Partnerships and collaboration models have become increasingly common as companies seek to combine platform access with best-in-class consumables. Service and training ecosystems are crucial competitive differentiators, as the ability to reduce the learning curve and deliver consistent outcomes influences purchasing decisions by hospitals and ambulatory centers. Moreover, manufacturers that offer comprehensive support programs covering simulation training, proctoring, and performance analytics position themselves as partners in clinical quality improvement rather than mere suppliers.

New entrants are carving out niches by addressing underserved needs, such as cost-sensitive instruments for ambulatory settings or compact visualization systems optimized for single-port workflows. At the same time, incumbents defend their positions by leveraging installed bases, long-term service agreements, and data-driven outcomes evidence. These dynamics mean that competitive advantage increasingly depends on the ability to craft end-to-end value propositions that integrate device performance, clinical training, and commercial flexibility.

Actionable strategic priorities for device developers and health systems to translate technological capability into durable clinical adoption and commercial resilience

Industry leaders should prioritize strategies that align technology development, commercial models, and clinical adoption pathways to accelerate sustainable uptake. First, invest in interoperability and modular architectures that enable instruments and consumables to be used across multiple platforms and procedural approaches, thereby reducing switching costs for hospitals and encouraging broader deployment in community and tertiary settings. Secondly, develop robust training and credentialing programs that combine simulation, proctoring, and post-market analytics to shorten the learning curve for surgeons adopting robotic, uniportal, or advanced video-assisted techniques.

Third, pursue flexible contracting approaches with hospitals and ambulatory centers that incorporate bundled services, outcome-linked clauses, and shared risk elements. These commercial innovations can help mitigate budgetary pressures and create durable procurement relationships. Fourth, strengthen regional go-to-market strategies by tailoring product configurations and support services to local reimbursement realities and supply chain considerations; this is particularly important in markets where local manufacturing partnerships or assembly can materially improve cost competitiveness. Finally, commit to collecting and publishing real-world outcomes that demonstrate comparative effectiveness and safety across procedure types and technologies, which will support clinical adoption and payer dialogues.

By executing these strategic priorities, industry leaders can convert technological capability into sustained clinical impact while addressing the operational and budgetary constraints that influence hospital and ambulatory purchasing decisions.

Integrated mixed-methods approach combining primary stakeholder engagement, clinical evidence review, device assessment, and supply chain analysis for actionable intelligence

This research synthesis draws on a mixed-methods approach combining primary stakeholder interviews, clinical literature review, device and technology assessments, and supply chain analysis to produce an integrated perspective on minimally invasive thoracic surgery. Primary interviews included surgical leaders, hospital procurement executives, ambulatory center administrators, and product managers from device firms to capture real-world decision criteria, adoption barriers, and service expectations. Clinical literature review focused on comparative studies, technique descriptions, and safety analyses to understand how procedural choices map to outcomes and workflow implications.

Device assessments examined design attributes, interoperability, service models, and training offerings to evaluate how product specifications influence adoption in different settings. Supply chain and procurement analyses explored sourcing strategies, tariff exposure, and regional manufacturing considerations to identify operational levers that stakeholders use to manage cost and continuity risk. Where possible, findings were triangulated across data sources to validate patterns and minimize single-source bias.

Throughout the methodology, emphasis was placed on extracting actionable intelligence that supports strategic decision-making rather than producing descriptive lists. Limitations of the approach include variability in regional reporting practices and differences in how institutions capture procedural outcomes, which were addressed by prioritizing triangulated insights and expert validation.

A forward-looking synthesis emphasizing integration of device design, clinical training, and commercial adaptability to ensure broad and sustainable adoption

In sum, minimally invasive thoracic surgery is at an inflection point in which device innovation, procedural refinement, and shifting care delivery models collectively shape the path forward. The interplay among procedure type selection, product capabilities, and institutional readiness determines not only clinical outcomes but also the speed and scale of technology adoption. As supply chain pressures and tariff changes influence commercial dynamics, stakeholders must adopt holistic strategies that align procurement, training, and clinical governance.

Looking ahead, the most successful organizations will be those that integrate modular product design, strong service and training ecosystems, and regionally attuned commercial models. By prioritizing interoperability, real-world evidence generation, and flexible contracting, manufacturers and providers can support broader access to minimally invasive thoracic techniques while managing financial and operational risk. Ultimately, the goal is to ensure that clinical advances translate into measurable improvements in patient care across diverse settings, from ambulatory centers to tertiary hospitals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expanding adoption of uniportal video-assisted thoracic surgery techniques to reduce patient recovery time
  • 5.2. Integration of artificial intelligence-driven imaging guidance for precise minimally invasive lung tumor resections
  • 5.3. Emergence of augmented reality navigation systems enhancing surgeon visualization in thoracic procedures
  • 5.4. Development of flexible endoscopic instruments enabling access to hard-to-reach pulmonary nodules with minimal trauma
  • 5.5. Growth of outpatient and same-day discharge protocols in minimally invasive thoracic surgery settings
  • 5.6. Advancements in energy-based sealing devices reducing intraoperative bleeding during thoracoscopic interventions
  • 5.7. Increasing investments in remote proctoring platforms for virtual surgeon training and skill assessment in MIS

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Minimally Invasive Thoracic Surgery Market, by Procedure Type

  • 8.1. Robotic Assisted Thoracoscopic Surgery
  • 8.2. Uniportal Vats
  • 8.3. Video Assisted Thoracoscopic Surgery

9. Minimally Invasive Thoracic Surgery Market, by Product

  • 9.1. Energy Devices
    • 9.1.1. Advanced Bipolar
    • 9.1.2. Electrocautery
    • 9.1.3. Ultrasonic
  • 9.2. Instruments
    • 9.2.1. Dissectors
    • 9.2.2. Graspers
    • 9.2.3. Scissors
  • 9.3. Staplers & Disposables
  • 9.4. Visualization Systems
    • 9.4.1. High Definition Systems
    • 9.4.2. Three D Endoscopes
    • 9.4.3. Two D Endoscopes

10. Minimally Invasive Thoracic Surgery Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Community Hospitals
    • 10.2.2. Tertiary Care Centers

11. Minimally Invasive Thoracic Surgery Market, by Technology

  • 11.1. Multi Port Systems
  • 11.2. Robotic Systems
  • 11.3. Single Port Systems

12. Minimally Invasive Thoracic Surgery Market, by Application

  • 12.1. Diagnostic
  • 12.2. Therapeutic

13. Minimally Invasive Thoracic Surgery Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Minimally Invasive Thoracic Surgery Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Minimally Invasive Thoracic Surgery Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Intuitive Surgical, Inc.
    • 16.3.2. Johnson & Johnson
    • 16.3.3. Medtronic plc
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Stryker Corporation
    • 16.3.6. Olympus Corporation
    • 16.3.7. Boston Scientific Corporation
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. KARL STORZ SE & Co. KG
    • 16.3.10. CONMED Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MINIMALLY INVASIVE THORACIC SURGERY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MINIMALLY INVASIVE THORACIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MINIMALLY INVASIVE THORACIC SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY UNIPORTAL VATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ADVANCED BIPOLAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ELECTROCAUTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DISSECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GRASPERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SCISSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STAPLERS & DISPOSABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HIGH DEFINITION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THREE D ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TWO D ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TERTIARY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MULTI PORT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SINGLE PORT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2